Tuesday, Dec 16th
Last update09:33:48 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
 With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on... |
 Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an... | ||
 A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby... |
|
